Archives of disease in childhood · 2022
Influence of epidemics and pandemics on paediatric ED use: a systematic review.
Систематический обзорСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Roland Damian, Gardiner Adam, Razzaq Darakhshan, Rose Katy, Bressan Silvia, Honeyford Kate, Buonsenso Danilo, Da Dalt Liviana, De Tisham, Farrugia Ruth, Parri Niccolo, Oostenbrink Rianne, Maconochie Ian K, Bognar Zsolt, Moll Henriette A, Titomanlio Luigi, Nijman Ruud Gerard Gerard, in association with the REPEM network (Research in European Paediatric Emergency Medicine) as part of the EPISODES Study
Аннотация
OBJECTIVE: To assess the impact of epidemics and pandemics on the utilisation of paediatric emergency care services to provide health policy advice.
SETTING: Systematic review.
DESIGN: Searches were conducted of Medline, EMBASE, CINAHL, Scopus, Web of Science and the Cochrane Library for studies that reported on changes in paediatric emergency care utilisation during epidemics (as defined by the WHO).
PATIENTS: Children under 18 years.
INTERVENTIONS: National Institutes of Health quality assessment tool for observational cohort and cross-sectional studies was used.
MAIN OUTCOME MEASURES: Changes in paediatric emergency care utilisation.
RESULTS: 131 articles were included within this review, 80% of which assessed the impact of COVID-19. Studies analysing COVID-19, SARS, Middle East respiratory syndrome (MERS) and Ebola found a reduction in paediatric emergency department (PED) visits, whereas studies reporting on H1N1, chikungunya virus and Escherichia coli outbreaks found an increase in PED visits. For COVID-19, there was a reduction of 63.86% (95% CI 60.40% to 67.31%) with a range of -16.5% to -89.4%. Synthesis of results suggests that the fear of the epidemic disease, from either contracting it or its potential adverse clinical outcomes, resulted in reductions and increases in PED utilisation, respectively.
CONCLUSIONS: The scale and direction of effect of PED use depend on both the epidemic disease, the public health measures enforced and how these influence decision-making. Policy makers must be aware how fear of virus among the general public may influence their response to public health advice. There is large inequity in reporting of epidemic impact on PED use which needs to be addressed.
TRIAL REGISTRATION NUMBER: CRD42021242808.
SETTING: Systematic review.
DESIGN: Searches were conducted of Medline, EMBASE, CINAHL, Scopus, Web of Science and the Cochrane Library for studies that reported on changes in paediatric emergency care utilisation during epidemics (as defined by the WHO).
PATIENTS: Children under 18 years.
INTERVENTIONS: National Institutes of Health quality assessment tool for observational cohort and cross-sectional studies was used.
MAIN OUTCOME MEASURES: Changes in paediatric emergency care utilisation.
RESULTS: 131 articles were included within this review, 80% of which assessed the impact of COVID-19. Studies analysing COVID-19, SARS, Middle East respiratory syndrome (MERS) and Ebola found a reduction in paediatric emergency department (PED) visits, whereas studies reporting on H1N1, chikungunya virus and Escherichia coli outbreaks found an increase in PED visits. For COVID-19, there was a reduction of 63.86% (95% CI 60.40% to 67.31%) with a range of -16.5% to -89.4%. Synthesis of results suggests that the fear of the epidemic disease, from either contracting it or its potential adverse clinical outcomes, resulted in reductions and increases in PED utilisation, respectively.
CONCLUSIONS: The scale and direction of effect of PED use depend on both the epidemic disease, the public health measures enforced and how these influence decision-making. Policy makers must be aware how fear of virus among the general public may influence their response to public health advice. There is large inequity in reporting of epidemic impact on PED use which needs to be addressed.
TRIAL REGISTRATION NUMBER: CRD42021242808.